Summary: Nemera adds GLP-1 drug market expansion news

Why It Matters: This shows Nemera is growing its ability to make GLP-1 drug devices.

What Changed:

• A news headline changed from "Our 2023 ESG report is published!" to "Nemera expands production capacity in Szczecin to strengthen leadership in GLP-1 drug market".
• A new news item was added: "Nemera joins forces with Women First to promote gender diversity in recruitment".